<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To investigate clinicopathological significance and prognostic implications of EphA3, CD133 and Ki-67 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: EphA3, CD133 and Ki-67 expression was assessed in 201 cases of paraffin-embedded colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> and 60 cases of distal <z:mpath ids='MPATH_458'>normal</z:mpath> mucosal tissue by immunohistochemistry </plain></SENT>
<SENT sid="2" pm="."><plain>Medical records were reviewed and clinicopathological analysis was performed </plain></SENT>
<SENT sid="3" pm="."><plain>The differential expression of EphA3 and CD133 protein was detected in 20 cases of fresh resected colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> and 20 cases of matched <z:mpath ids='MPATH_458'>normal</z:mpath> mucosal tissue adjacent to the <z:mp ids='MP_0002038'>carcinoma</z:mp> by western blot </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The expression of EphA3 and CD133 in <z:mp ids='MP_0002038'>carcinoma</z:mp> was significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosal tissue (p=0.008; p=0.004) </plain></SENT>
<SENT sid="5" pm="."><plain>EphA3 and CD133 were positively correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> size (p=0.029; p=0.017), histological grade (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.001), infiltrative depth (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.00), lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.00), distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p=0.017; p=0.030) and TNM stage (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with high expression of EphA3 and CD133 had the lowest survival (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.001) (median survival time of EphA3 positive and negative cases: 34.0 and 72.0 months; median survival time of CD133 positive and negative cases: 34.0 and 77.0 months) </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate survival analysis showed that EphA3 and CD133 expression was correlated significantly with shortened survival in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (Cox regression: p=0.001, HR=4.722, 95% CI 2.667 to 8.361; p=0.001, HR=5.224, 95% CI 2.622 to 10.405) </plain></SENT>
<SENT sid="8" pm="."><plain>EphA3, CD133 and Ki-67 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> had positive correlations with each other (<z:hpo ids='HP_0000001'>all</z:hpo> p=0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: EphA3 and CD133 may play an important role in the development and progression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, and thus become useful indicators for clinical assessment of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> biological behaviour and prognosis in patients with colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>